Robert Lally, Senior Vice President of Finance and Operations and principal accounting officer, resigned on June 22, 2026, effective July 22, 2026. The company stated the resignation was not due to any disagreement and is searching for a replacement. ImageneBio, Inc. operates in the biotechnology industry, focusing on genetic medicine and therapeutics.
